Akb-6548-Ci-0014
Research payments
$7,894,765
Through program year 2022, $7,894,765 in research payments was reported against Akb-6548-Ci-0014, across 9,996 payments, paid by Akebia Therapeutics Inc.
- Paid by
- Akebia Therapeutics Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $246,126 | 391 |
| 2019 | Research | $7,648,639 | 9,605 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Fausto Castillo Miami, FL Named on 364 payments
- Arvind Mehta Long Beach, CA Named on 318 payments
- Adeel Ijaz MacOmb, MI Named on 308 payments
- Sohan Dua Northridge, CA Named on 306 payments
- Moustafa Moustafa Orangeburg, SC Named on 301 payments
- Andrew O'Shaughnessy Fort Wayne, IN Named on 269 payments
- Harold Hubert Augusta, GA Named on 245 payments
- Gopal Krishna Salinas, CA Named on 238 payments
- Kamal Gandhi Granada Hills, CA Named on 225 payments
- Pablo Pergola San Antonio, TX Named on 223 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.